4th Quarter - Report

BUCHANAN INGERSOLL & ROONEY PC for IPEC - AMERICAS, INC.

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

FDA Globalization Acts and legislation related to supply chain security and drug contamination issues

LobbyistCovered position, as disclosed
MARK LENKER —
ROBERT PINCO —
JAMES C WILTRAUT —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.